Please login to the form below

Not currently logged in


This page shows the latest lumacaftor news and features for those working in and with pharma, biotech and healthcare.

Vertex's two-drug cystic fibrosis treatment cleared in US

Vertex's two-drug cystic fibrosis treatment cleared in US

Vertex already markets a two-drug combination called Orkambi which combines ivacaftor with lumacaftor, which brought in $1.3bn in sales last year to overtake Kalydeco’s $845m turnover.

Latest news

More from news
Approximately 4 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...